Year archive

Zhaoke Ophthalmology Limited — 2022 filings

All 55 regulatory filings released by Zhaoke Ophthalmology Limited (6622) in 2022, sourced directly from the official regulator.

55 Filings

2022 Period

2022 filings (55)

Filing	Released	Lang
Remuneration Committee - Terms of Reference Governance Information	2022-12-22	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2022-12-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-01	English
Voluntary Announcement - Reaching Exclusive Distribution Agreement to Commercialize Tono-i in Greater China for Self-measurement of Intraocular Pressure Regulatory Filings	2022-11-08	English
Voluntary Announcement - Patient Enrollments Complete for ZKY001 of Phase II Clinical Trial for TPRK, Phase II Clinical Trial for Pterygium and IIT for NK Regulatory Filings	2022-11-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Regulatory Filings	2022-11-02	English
Voluntary Announcement - Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children Announced Regulatory Filings	2022-10-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Share Issue/Capital Change	2022-10-03	English
Notification Letter to Registered Shareholders (Notice of Publication of 2022 Interim Report) and Change Request Form Report Publication Announcement	2022-09-15	English
Notification Letter to Non-registered Shareholders (Notice of Publication of 2022 Interim Report) and Request Form Report Publication Announcement	2022-09-15	English
2022 Interim Report Interim / Quarterly Report H1 2022	2022-09-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Regulatory Filings	2022-09-01	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Interim / Quarterly Report H1 2022	2022-08-24	English
NOTICE OF BOARD MEETING Report Publication Announcement	2022-08-12	English
Voluntary Announcement - First Patient Enrolled In Phase II Clinical Trial of ZKY001 for TPRK Regulatory Filings	2022-08-10	English
Voluntary Announcement - Patient Enrollment Complete for Phase III Clinical Trials of NVK002 for Treatment of Myopia Progression Regulatory Filings	2022-08-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Regulatory Filings	2022-08-02	English
Reply Form Regulatory Filings	2022-07-22	English
Election of Language and Means of Re ceipt of Corporate Communications Report Publication Announcement	2022-07-22	English
ELECTION OF LANGUAGE AND MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS Regulatory Filings	2022-07-22	English
Voluntary Announcement - First Patient Enrolled in TAB014 Phase III Clinical Trial in China Regulatory Filings	2022-07-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-05	English
Voluntary Announcement - New Drug Application of Cyclosporine A Ophthalmic Gel is Accepted for Review by the Center for Drug Evaluation Regulatory Filings	2022-06-08	English
List of Directors and their Roles and Functions Board/Management Information	2022-06-06	English
(1) Appointment of Independent Non-Executive Director; (2) Change in Composition of the Audit Committee; (3) Updates on Non-Compliance with the Listing Rules Board/Management Information	2022-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Regulatory Filings	2022-06-01	English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2022-05-31	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 31, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-05-31	English
Environmental, Social and Governance Report 2021 Environmental & Social Information	2022-05-30	English
Voluntary Announcement - First Patient Enrolled For NVK002 Phase III Bridging Clinical Trial (Mini-CHAMP) in China Regulatory Filings	2022-05-19	English
Voluntary Announcement - Reaching Exclusive Licensing Agreement to Commercialize BRIMOCHOL PF and CARBACHOL PF In Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Pre Regulatory Filings	2022-05-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-03	English
Notification letter to Non-registered Shareholders for Online AGM Attendance AGM Information	2022-04-25	English
Notification letter to Registered Shareholders for Online AGM Attendance AGM Information	2022-04-25	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2022-04-25	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, MAY 31, 2022 AGM Information	2022-04-25	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-04-25	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; (4) AGM Information	2022-04-25	English
Annual Report 2021 Regulatory Filings	2022-04-25	English
SUPPLEMENTAL ANNOUNCEMENT CONTINUING CONNECTED TRANSACTION PROCUREMENT OF CRO SERVICES FOR NVK002 Regulatory Filings	2022-04-14	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2022-04-11	English
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-COMPLIANCE WITH LISTING RULES REQUIREMENTS Board/Management Information	2022-04-11	English
CONTINUING CONNECTED TRANSACTIONS ANNOUNCEMENT PROCUREMENT OF CRO SERVICES FOR NVK002 Regulatory Filings	2022-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Share Issue/Capital Change	2022-04-04	English
PROPOSED ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2022-03-23	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED FOR NVK002 PHASE III CLINICAL TRIAL IN CHINA Regulatory Filings	2022-03-23	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021 Annual Report FY 2021	2022-03-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2022-03-14	English
Voluntary Announcement - Entering into a Supplemental Agreement with TOT BIOPHARM for Drug Marketing Licensing, Development and Commercialization of TAB014 Capital/Financing Update	2022-03-09	English
Connected Transaction Announcement - Renewal of the Lease agreement Capital/Financing Update	2022-03-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 Regulatory Filings	2022-03-01	English
Voluntary Announcement - Current Use Corporate Gift Agreement in Relation to Donation to Johns Hopkins University to Support Translational Research and Academic Exchanges Regulatory Filings	2022-02-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 Regulatory Filings	2022-02-07	English
ANNOUNCEMENT - LAST PATIENT ENROLLED FOR PHASE II CLINICAL TRIAL OF ZKY001 FOR CORNEAL EPITHELIAL DEFECTS AND TERMINATION OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO PROCUREMENT OF CRO SERVICE Regulatory Filings	2022-01-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 Regulatory Filings	2022-01-04	English